Hazlewoods Corporate Finance team, led by Paul Fussell, is pleased to announce that they have recently advised on the acquisition of Vacgen Limited (Vacgen), by Agathos Management LLP (Agathos) from Scienta Scientific AB (Scienta).
Vacgen is a market-leading and globally recognised manufacturer of UHV chambers, components and manipulation devices used in advanced scientific research. The company is based in East Sussex, UK and employs approximately 80 people.
Leading up to the sale, Scienta consolidated their UHV offering by merging two subsidiaries: Vacgen and Omicron UHV Tecknik Limited. The enlarged business also opened a new purpose built facility and implemented LEAN manufacturing principles.
Hazlewoods provided financial due diligence services, advising on all aspects of the transaction.
Paul Fussell, Partner at Hazlewoods, said: “As part of the Scienta group, Vacgen started a significant corporate restructure and process rationalisation. Following the acquisition by Agathos, the management team are well placed to continue this journey, focusing on the business’ core strengths.”